Figure 2.

IHT derives microglia toward the anti-inflammatory M2 phenotype. (a) The characteristic of EOC20 cell is confirmed by detecting CD11b which is a microglia marker. CD206, M2 marker, is noticeably increased on the microglia treated with IHT. (b,c) Western blot data clearly show that CD206 protein content in the microglia is significantly increased by IHT compared to the microglia in the OGD and reoxygenation group. *P < 0.05 vs. OGD/Reoxy. (A color version of this figure is available in the online journal.)